Quick Answer
Glucotrack, Inc. reported Stockholders Equity of $2.83 million for fiscal year 2025.
Glucotrack, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.83M | +121.8% |
| 2024 | -$13.00M | -506.6% |
| 2023 | $3.20M | +159.9% |
| 2022 | $1.23M | -76.1% |
| 2021 | $5.16M | -42.6% |
| 2020 | $8.98M | +736.1% |
| 2019 | -$1.41M | +50.9% |
| 2018 | -$2.87M | +82.7% |
| 2017 | -$16.57M | -51.4% |
| 2016 | -$10.95M | -57.1% |
| 2015 | -$6.97M | -44.3% |
| 2014 | -$4.83M | +56.3% |
| 2013 | -$11.06M | -2099.1% |
| 2012 | -$503.1K | -152.0% |
| 2011 | $968.2K | +61.9% |
| 2010 | $598.1K | +177.1% |
| 2009 | -$775.7K | -1659.3% |
| 2008 | $49.8K | -90.8% |
| 2007 | $542.2K | -69.5% |
| 2006 | $1.78M | +757.7% |
| 2005 | -$270.1K | +44.6% |
| 2004 | -$487.6K | -25.6% |
| 2003 | -$388.2K | -1598.4% |
| 2002 | -$22.9K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.75M | +168.4% | -60.0% |
| June 30, 2025 | $6.88M | +309.2% | -5.3% |
| March 31, 2025 | $7.26M | +1836.8% | +155.9% |
| December 31, 2024 | -$13.00M | -506.6% | -223.2% |
| September 30, 2024 | -$4.02M | -172.4% | -22.3% |
| June 30, 2024 | -$3.29M | -142.5% | -977.1% |
| March 31, 2024 | $375.0K | +3309.1% | -88.3% |
| December 31, 2023 | $3.20M | +159.9% | -42.5% |
- Glucotrack, Inc. showed an increase of +121.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2002–2025 period, Glucotrack, Inc.’s stockholders equity has grown by 12473.1% (from -$22.9 thousand to $2.83 million).
- The most recent figure is from Glucotrack, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: